Funded Tech Companies

Domain Therapeutics

Wondering who backed Domain Therapeutics? OMNES Capital, 3B Future Health Fund and Panacea Venture put venture money into this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

We are committed to improve patients' life and to support physicians by delivering innovative immunotherapies to fight cancer. We aim at making an impactful difference for patients suffering from cancer by discovering first-in-class and best-in-class treatments to tackle GPCR-mediated immunosuppression. Leveraging our expertise, innovative approach and proprietary platform, we develop a unique pipeline in immune-oncology and progress our most advanced programs towards the clinic.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

5/10/2022

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Pascal Neuville

        

Chief Financial Officer

Stanislas Malmezat

        

Chief Scientific Officer

Xavier Leroy

        

VP - Bus. Development

Marjorie Sidhoum

        

VP - Human Resources

Aurélie Maisner

        

Company Investors

• OMNES Capital
• 3B Future Health Fund (Roberto Ponti)
• Panacea Venture (James Huang)
• Viva BioInnovator
• Theodorus
• Turenne
• CTI Life Sciences Fund (Laurence Rulleau)
• Seventure Partners (Emmanuel Fiessinger)
• adMare BioInnovations
• Schroders Capital (Erwin Boos)

Browse more funded tech companies:

Domain Surgical | Domantis

Share this article

About Our Venture Capital Database

The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary